Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Osteogenesis | 17 | 2015 | 96 | 2.490 |
Why?
|
Transforming Growth Factor beta | 11 | 2014 | 81 | 2.150 |
Why?
|
Femur | 17 | 2015 | 352 | 1.660 |
Why?
|
Ultrasonic Therapy | 5 | 2017 | 17 | 1.440 |
Why?
|
Rats | 33 | 2021 | 598 | 1.430 |
Why?
|
Bone Morphogenetic Protein 2 | 7 | 2014 | 43 | 1.400 |
Why?
|
Rats, Sprague-Dawley | 28 | 2021 | 304 | 1.310 |
Why?
|
Bone Morphogenetic Proteins | 7 | 2015 | 50 | 1.290 |
Why?
|
Animals | 52 | 2021 | 3377 | 1.240 |
Why?
|
Prostheses and Implants | 11 | 2020 | 150 | 1.200 |
Why?
|
Bone Regeneration | 10 | 2015 | 68 | 1.170 |
Why?
|
Osteoporosis | 4 | 2020 | 74 | 1.130 |
Why?
|
Osseointegration | 6 | 2021 | 65 | 0.980 |
Why?
|
Bone Marrow Cells | 9 | 2010 | 47 | 0.930 |
Why?
|
Awards and Prizes | 1 | 2022 | 19 | 0.800 |
Why?
|
Mentoring | 1 | 2022 | 26 | 0.770 |
Why?
|
Stromal Cells | 4 | 2010 | 32 | 0.750 |
Why?
|
Titanium | 10 | 2021 | 164 | 0.730 |
Why?
|
Implants, Experimental | 6 | 2021 | 29 | 0.730 |
Why?
|
Fracture Healing | 4 | 2017 | 37 | 0.660 |
Why?
|
Bone and Bones | 10 | 2017 | 107 | 0.630 |
Why?
|
Prosthesis Failure | 5 | 2020 | 482 | 0.540 |
Why?
|
Gene Expression Regulation | 4 | 2014 | 232 | 0.520 |
Why?
|
Bone Marrow | 3 | 2015 | 73 | 0.490 |
Why?
|
Disease Models, Animal | 7 | 2017 | 512 | 0.490 |
Why?
|
X-Ray Microtomography | 8 | 2021 | 77 | 0.490 |
Why?
|
Gene Expression Profiling | 5 | 2010 | 125 | 0.490 |
Why?
|
Prosthesis Implantation | 2 | 2012 | 29 | 0.480 |
Why?
|
Osteoblasts | 8 | 2015 | 50 | 0.470 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2014 | 48 | 0.460 |
Why?
|
Recombinant Proteins | 8 | 2014 | 186 | 0.460 |
Why?
|
Calcitonin | 1 | 2014 | 14 | 0.460 |
Why?
|
Parathyroid Hormone | 1 | 2014 | 22 | 0.460 |
Why?
|
Fracture Fixation | 1 | 2014 | 22 | 0.460 |
Why?
|
Diphosphonates | 1 | 2014 | 14 | 0.460 |
Why?
|
Bone Density Conservation Agents | 1 | 2014 | 13 | 0.460 |
Why?
|
Osteoporotic Fractures | 1 | 2014 | 12 | 0.450 |
Why?
|
Cell Differentiation | 4 | 2010 | 111 | 0.440 |
Why?
|
Antibodies, Monoclonal | 5 | 2012 | 195 | 0.440 |
Why?
|
Osteolysis | 4 | 2020 | 137 | 0.430 |
Why?
|
Receptors, CXCR4 | 2 | 2012 | 16 | 0.420 |
Why?
|
Male | 31 | 2020 | 13545 | 0.420 |
Why?
|
Chemokine CXCL12 | 1 | 2012 | 8 | 0.400 |
Why?
|
Dose-Response Relationship, Drug | 6 | 2014 | 307 | 0.380 |
Why?
|
Gap Junctions | 1 | 2011 | 12 | 0.370 |
Why?
|
Cell Communication | 1 | 2011 | 23 | 0.370 |
Why?
|
Gene Expression | 5 | 2011 | 176 | 0.370 |
Why?
|
Cells, Cultured | 10 | 2011 | 467 | 0.360 |
Why?
|
Bone Remodeling | 4 | 2019 | 43 | 0.350 |
Why?
|
Antibodies | 3 | 2015 | 36 | 0.340 |
Why?
|
Ultrasonics | 2 | 2005 | 9 | 0.310 |
Why?
|
Osteocytes | 3 | 2014 | 15 | 0.300 |
Why?
|
Low-Level Light Therapy | 2 | 2017 | 3 | 0.300 |
Why?
|
Bone Resorption | 5 | 2015 | 74 | 0.280 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2007 | 62 | 0.270 |
Why?
|
Models, Animal | 10 | 2017 | 94 | 0.270 |
Why?
|
Anabolic Agents | 1 | 2004 | 3 | 0.240 |
Why?
|
Graft Survival | 1 | 2004 | 81 | 0.240 |
Why?
|
Osteocalcin | 5 | 2019 | 22 | 0.230 |
Why?
|
Inflammation | 2 | 2020 | 253 | 0.230 |
Why?
|
Genetic Markers | 2 | 2015 | 44 | 0.230 |
Why?
|
Biomarkers | 4 | 2019 | 537 | 0.220 |
Why?
|
Heterocyclic Compounds | 2 | 2012 | 7 | 0.200 |
Why?
|
Financing, Organized | 1 | 2022 | 8 | 0.200 |
Why?
|
Ovariectomy | 3 | 2021 | 22 | 0.200 |
Why?
|
Biomechanical Phenomena | 5 | 2020 | 588 | 0.200 |
Why?
|
Fellowships and Scholarships | 1 | 2022 | 35 | 0.190 |
Why?
|
Faculty, Medical | 1 | 2022 | 36 | 0.190 |
Why?
|
Coated Materials, Biocompatible | 3 | 2007 | 39 | 0.190 |
Why?
|
Bone Matrix | 2 | 2014 | 24 | 0.190 |
Why?
|
Prosthesis Retention | 1 | 2020 | 4 | 0.180 |
Why?
|
Bone-Implant Interface | 1 | 2020 | 7 | 0.180 |
Why?
|
Humans | 18 | 2022 | 25178 | 0.180 |
Why?
|
Signal Transduction | 3 | 2012 | 380 | 0.180 |
Why?
|
Vitallium | 2 | 2011 | 23 | 0.180 |
Why?
|
Joint Prosthesis | 1 | 2020 | 72 | 0.170 |
Why?
|
Myositis Ossificans | 1 | 1999 | 2 | 0.170 |
Why?
|
Body Weight | 1 | 2019 | 117 | 0.170 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2011 | 174 | 0.160 |
Why?
|
Collagen | 4 | 2012 | 65 | 0.160 |
Why?
|
Osteosarcoma | 1 | 1998 | 34 | 0.160 |
Why?
|
Cartilage, Articular | 3 | 2008 | 374 | 0.150 |
Why?
|
Gastrointestinal Microbiome | 1 | 2020 | 179 | 0.150 |
Why?
|
Prosthesis-Related Infections | 1 | 2020 | 179 | 0.150 |
Why?
|
Materials Testing | 5 | 2012 | 124 | 0.150 |
Why?
|
Stem Cells | 1 | 2017 | 37 | 0.150 |
Why?
|
Polymers | 2 | 2007 | 40 | 0.140 |
Why?
|
Calcium Phosphates | 3 | 2005 | 22 | 0.140 |
Why?
|
Polyethylene | 2 | 2019 | 116 | 0.140 |
Why?
|
Biomimetic Materials | 2 | 2006 | 6 | 0.130 |
Why?
|
Random Allocation | 2 | 2012 | 106 | 0.130 |
Why?
|
Combined Modality Therapy | 2 | 2014 | 268 | 0.130 |
Why?
|
Benzylamines | 2 | 2012 | 11 | 0.130 |
Why?
|
Cobalt | 2 | 2014 | 107 | 0.120 |
Why?
|
Up-Regulation | 2 | 2007 | 131 | 0.120 |
Why?
|
Cell Line | 5 | 2014 | 240 | 0.120 |
Why?
|
Nickel | 1 | 2014 | 30 | 0.120 |
Why?
|
Wnt Proteins | 2 | 2012 | 15 | 0.120 |
Why?
|
Orthopedic Fixation Devices | 1 | 2014 | 19 | 0.120 |
Why?
|
Thiophenes | 1 | 2014 | 10 | 0.120 |
Why?
|
Glycoproteins | 1 | 2014 | 46 | 0.120 |
Why?
|
Bone Diseases, Metabolic | 1 | 2014 | 18 | 0.110 |
Why?
|
Matrix Metalloproteinases | 2 | 2010 | 15 | 0.110 |
Why?
|
Transforming Growth Factor beta2 | 4 | 2006 | 14 | 0.110 |
Why?
|
Female | 9 | 2021 | 13844 | 0.110 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2010 | 44 | 0.110 |
Why?
|
Fractures, Bone | 1 | 2014 | 73 | 0.110 |
Why?
|
Bone Transplantation | 2 | 2005 | 197 | 0.110 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2012 | 2 | 0.100 |
Why?
|
Adult Stem Cells | 1 | 2012 | 2 | 0.100 |
Why?
|
Tensile Strength | 1 | 2012 | 23 | 0.100 |
Why?
|
Time Factors | 5 | 2012 | 1327 | 0.100 |
Why?
|
Drug Administration Schedule | 1 | 2012 | 151 | 0.100 |
Why?
|
Cell Movement | 1 | 2012 | 72 | 0.100 |
Why?
|
Reference Values | 1 | 2012 | 185 | 0.100 |
Why?
|
Alkaline Phosphatase | 2 | 2010 | 16 | 0.100 |
Why?
|
Electron Microscope Tomography | 1 | 2011 | 2 | 0.100 |
Why?
|
Calcineurin | 1 | 2011 | 9 | 0.100 |
Why?
|
NFATC Transcription Factors | 1 | 2011 | 14 | 0.090 |
Why?
|
RNA, Messenger | 6 | 2005 | 240 | 0.090 |
Why?
|
Radiation Dosage | 1 | 2011 | 34 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2010 | 11 | 0.090 |
Why?
|
Transducers | 1 | 2010 | 9 | 0.090 |
Why?
|
Tissue Engineering | 2 | 2007 | 28 | 0.090 |
Why?
|
Matrix Metalloproteinase 13 | 2 | 2007 | 24 | 0.090 |
Why?
|
Bayes Theorem | 1 | 2010 | 37 | 0.090 |
Why?
|
Mice | 5 | 2015 | 1197 | 0.090 |
Why?
|
Statistics, Nonparametric | 1 | 2010 | 116 | 0.090 |
Why?
|
Blotting, Western | 1 | 2010 | 128 | 0.090 |
Why?
|
Phosphorylation | 1 | 2010 | 135 | 0.090 |
Why?
|
Extracellular Matrix | 2 | 2008 | 33 | 0.090 |
Why?
|
Metals | 1 | 2011 | 137 | 0.090 |
Why?
|
Equipment Design | 1 | 2010 | 137 | 0.090 |
Why?
|
Risk Assessment | 1 | 2012 | 592 | 0.090 |
Why?
|
Biocompatible Materials | 2 | 2007 | 87 | 0.080 |
Why?
|
Femoral Fractures | 2 | 2006 | 32 | 0.080 |
Why?
|
Stress, Mechanical | 2 | 2007 | 146 | 0.080 |
Why?
|
Chondrocytes | 2 | 2008 | 136 | 0.080 |
Why?
|
Sialoglycoproteins | 2 | 2007 | 8 | 0.080 |
Why?
|
Cartilage | 2 | 2008 | 93 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 106 | 0.080 |
Why?
|
Growth Substances | 2 | 2005 | 29 | 0.080 |
Why?
|
Freezing | 1 | 2008 | 12 | 0.080 |
Why?
|
Fibroblasts | 2 | 2001 | 57 | 0.070 |
Why?
|
Cryopreservation | 1 | 2008 | 17 | 0.070 |
Why?
|
Down-Regulation | 2 | 2005 | 90 | 0.070 |
Why?
|
Surface Properties | 3 | 2019 | 126 | 0.070 |
Why?
|
Acrylic Resins | 1 | 2007 | 2 | 0.070 |
Why?
|
Cell Culture Techniques | 2 | 2004 | 26 | 0.070 |
Why?
|
Dactinomycin | 1 | 2007 | 4 | 0.070 |
Why?
|
Cycloheximide | 1 | 2007 | 7 | 0.070 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2007 | 6 | 0.070 |
Why?
|
Growth Differentiation Factor 5 | 1 | 2007 | 5 | 0.070 |
Why?
|
Guided Tissue Regeneration | 1 | 2006 | 9 | 0.070 |
Why?
|
Phenotype | 2 | 2015 | 283 | 0.070 |
Why?
|
Menisci, Tibial | 1 | 2008 | 155 | 0.070 |
Why?
|
Durapatite | 1 | 2005 | 7 | 0.060 |
Why?
|
Organ Preservation | 1 | 2005 | 5 | 0.060 |
Why?
|
Genes, jun | 1 | 2005 | 3 | 0.060 |
Why?
|
Early Growth Response Protein 1 | 1 | 2005 | 4 | 0.060 |
Why?
|
Osteonectin | 1 | 2005 | 4 | 0.060 |
Why?
|
Immediate-Early Proteins | 1 | 2005 | 4 | 0.060 |
Why?
|
Osteopontin | 1 | 2005 | 4 | 0.060 |
Why?
|
Genes, myc | 1 | 2005 | 5 | 0.060 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2005 | 23 | 0.060 |
Why?
|
Cyclooxygenase 2 | 1 | 2005 | 25 | 0.060 |
Why?
|
Repressor Proteins | 1 | 2005 | 23 | 0.060 |
Why?
|
Sodium Chloride | 1 | 2005 | 32 | 0.060 |
Why?
|
Bone Marrow Purging | 1 | 2004 | 2 | 0.060 |
Why?
|
Extracellular Matrix Proteins | 1 | 2004 | 63 | 0.060 |
Why?
|
Interleukin-6 | 2 | 2009 | 66 | 0.060 |
Why?
|
Microscopy, Fluorescence | 2 | 2014 | 77 | 0.060 |
Why?
|
Transcription Factors | 1 | 2005 | 150 | 0.060 |
Why?
|
Treatment Outcome | 1 | 2012 | 3146 | 0.060 |
Why?
|
Regeneration | 2 | 2015 | 17 | 0.060 |
Why?
|
DNA-Binding Proteins | 1 | 2005 | 250 | 0.050 |
Why?
|
Proteoglycans | 3 | 2008 | 124 | 0.050 |
Why?
|
Cell Survival | 3 | 2008 | 102 | 0.050 |
Why?
|
Mice, Inbred C57BL | 2 | 2015 | 358 | 0.050 |
Why?
|
Dogs | 3 | 2008 | 176 | 0.050 |
Why?
|
Tumor Cells, Cultured | 2 | 1999 | 117 | 0.050 |
Why?
|
Rats, Zucker | 1 | 2021 | 7 | 0.050 |
Why?
|
Cell Death | 2 | 2014 | 40 | 0.050 |
Why?
|
Retroviridae | 1 | 2001 | 4 | 0.050 |
Why?
|
Transplantation, Heterologous | 1 | 2001 | 16 | 0.050 |
Why?
|
Adolescent | 3 | 2008 | 1998 | 0.050 |
Why?
|
Cell Transplantation | 1 | 2001 | 19 | 0.050 |
Why?
|
Skull | 1 | 2001 | 21 | 0.050 |
Why?
|
Bone Density | 2 | 2014 | 135 | 0.050 |
Why?
|
Cattle | 3 | 2008 | 145 | 0.040 |
Why?
|
Osteogenesis, Distraction | 1 | 2000 | 11 | 0.040 |
Why?
|
Calcification, Physiologic | 1 | 2019 | 19 | 0.040 |
Why?
|
Genetic Heterogeneity | 1 | 1999 | 8 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 3 | 2012 | 685 | 0.040 |
Why?
|
Pedigree | 1 | 1999 | 66 | 0.040 |
Why?
|
Lipopolysaccharides | 1 | 2019 | 95 | 0.040 |
Why?
|
RNA | 1 | 1999 | 32 | 0.040 |
Why?
|
Genetic Linkage | 1 | 1999 | 56 | 0.040 |
Why?
|
Osteoclasts | 1 | 1999 | 20 | 0.040 |
Why?
|
Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 1998 | 1 | 0.040 |
Why?
|
Bone Morphogenetic Protein 4 | 1 | 1998 | 1 | 0.040 |
Why?
|
Oligonucleotide Probes | 1 | 1998 | 3 | 0.040 |
Why?
|
Blotting, Northern | 1 | 1998 | 18 | 0.040 |
Why?
|
Tretinoin | 1 | 1998 | 14 | 0.040 |
Why?
|
Dinoprostone | 1 | 1998 | 15 | 0.040 |
Why?
|
Cholecalciferol | 1 | 1998 | 6 | 0.040 |
Why?
|
Arthroplasty, Replacement | 1 | 2020 | 139 | 0.040 |
Why?
|
Interleukin-1 | 1 | 1998 | 39 | 0.040 |
Why?
|
Actins | 1 | 1998 | 32 | 0.040 |
Why?
|
Interferon-alpha | 1 | 1998 | 30 | 0.040 |
Why?
|
Receptors, Estrogen | 1 | 1999 | 57 | 0.040 |
Why?
|
Transcription, Genetic | 1 | 1998 | 86 | 0.040 |
Why?
|
Infant | 1 | 1999 | 483 | 0.040 |
Why?
|
Adipocytes | 1 | 1997 | 11 | 0.040 |
Why?
|
In Situ Hybridization | 3 | 2005 | 32 | 0.040 |
Why?
|
Child, Preschool | 1 | 1999 | 588 | 0.040 |
Why?
|
Adult | 4 | 2008 | 7087 | 0.040 |
Why?
|
Motor Activity | 1 | 2019 | 305 | 0.040 |
Why?
|
Oligopeptides | 2 | 2007 | 21 | 0.040 |
Why?
|
Hip Prosthesis | 1 | 2002 | 516 | 0.030 |
Why?
|
Temperature | 2 | 2008 | 56 | 0.030 |
Why?
|
Microscopy, Confocal | 2 | 2007 | 104 | 0.030 |
Why?
|
Microscopy, Electron, Scanning | 2 | 2007 | 69 | 0.030 |
Why?
|
Transplantation, Homologous | 2 | 2008 | 249 | 0.030 |
Why?
|
DNA Primers | 2 | 2005 | 45 | 0.030 |
Why?
|
Mice, Inbred C3H | 1 | 2015 | 18 | 0.030 |
Why?
|
Mice, Inbred Strains | 1 | 2015 | 21 | 0.030 |
Why?
|
Species Specificity | 1 | 2015 | 40 | 0.030 |
Why?
|
Mice, Inbred BALB C | 1 | 2015 | 79 | 0.030 |
Why?
|
Microscopy, Phase-Contrast | 1 | 2014 | 4 | 0.030 |
Why?
|
Molybdenum | 1 | 2014 | 20 | 0.030 |
Why?
|
Diaphyses | 1 | 2014 | 4 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 85 | 0.030 |
Why?
|
Epitopes | 1 | 1994 | 40 | 0.030 |
Why?
|
Macaca fascicularis | 1 | 2014 | 19 | 0.030 |
Why?
|
Organ Specificity | 1 | 2014 | 39 | 0.030 |
Why?
|
Chromium | 1 | 2014 | 86 | 0.030 |
Why?
|
Mice, Transgenic | 1 | 2014 | 183 | 0.030 |
Why?
|
Cell Lineage | 2 | 2007 | 24 | 0.030 |
Why?
|
Rabbits | 4 | 2000 | 217 | 0.030 |
Why?
|
Humerus | 1 | 2014 | 99 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2007 | 539 | 0.030 |
Why?
|
Periosteum | 1 | 2012 | 4 | 0.030 |
Why?
|
Alloys | 2 | 2004 | 87 | 0.030 |
Why?
|
Colony-Forming Units Assay | 1 | 2012 | 4 | 0.030 |
Why?
|
Hematopoietic Stem Cells | 1 | 2012 | 10 | 0.030 |
Why?
|
Flow Cytometry | 1 | 2012 | 99 | 0.030 |
Why?
|
Endothelial Cells | 1 | 2012 | 57 | 0.020 |
Why?
|
Keratan Sulfate | 1 | 1992 | 18 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2012 | 145 | 0.020 |
Why?
|
Tibia | 1 | 2014 | 228 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2014 | 642 | 0.020 |
Why?
|
Immunohistochemistry | 3 | 2000 | 300 | 0.020 |
Why?
|
Calcineurin Inhibitors | 1 | 2011 | 15 | 0.020 |
Why?
|
Pilot Projects | 1 | 2012 | 358 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2011 | 74 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2011 | 97 | 0.020 |
Why?
|
Radiography | 1 | 2012 | 572 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2011 | 121 | 0.020 |
Why?
|
Rats, Long-Evans | 1 | 2009 | 11 | 0.020 |
Why?
|
Cell Division | 2 | 2001 | 71 | 0.020 |
Why?
|
Ossification, Heterotopic | 1 | 2009 | 31 | 0.020 |
Why?
|
Lumbar Vertebrae | 1 | 2014 | 388 | 0.020 |
Why?
|
Apoptosis | 1 | 2009 | 187 | 0.020 |
Why?
|
Preservation, Biological | 1 | 2008 | 3 | 0.020 |
Why?
|
Cold Temperature | 1 | 2008 | 13 | 0.020 |
Why?
|
Histocytochemistry | 1 | 2008 | 14 | 0.020 |
Why?
|
Hot Temperature | 1 | 2008 | 17 | 0.020 |
Why?
|
Compressive Strength | 1 | 2008 | 21 | 0.020 |
Why?
|
Nitric Oxide Synthase | 1 | 2008 | 44 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2007 | 29 | 0.020 |
Why?
|
Nitric Oxide | 1 | 2008 | 84 | 0.020 |
Why?
|
Acrylates | 1 | 2007 | 2 | 0.020 |
Why?
|
Ethylene Glycol | 1 | 2007 | 3 | 0.020 |
Why?
|
Biomimetics | 1 | 2006 | 4 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2007 | 239 | 0.020 |
Why?
|
Drug Synergism | 1 | 2006 | 38 | 0.020 |
Why?
|
Middle Aged | 3 | 2008 | 8135 | 0.020 |
Why?
|
Models, Biological | 1 | 2008 | 299 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2006 | 162 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2005 | 25 | 0.020 |
Why?
|
Sulfur Radioisotopes | 1 | 2005 | 12 | 0.020 |
Why?
|
Sulfates | 1 | 2005 | 10 | 0.020 |
Why?
|
Shear Strength | 1 | 2005 | 7 | 0.020 |
Why?
|
Hydroxyapatites | 1 | 2005 | 9 | 0.020 |
Why?
|
Delayed-Action Preparations | 1 | 2005 | 27 | 0.020 |
Why?
|
Bone Morphogenetic Protein 7 | 1 | 2005 | 18 | 0.020 |
Why?
|
Base Sequence | 1 | 2005 | 86 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2005 | 111 | 0.020 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2011 | 754 | 0.010 |
Why?
|
Amino Acids | 1 | 2002 | 17 | 0.010 |
Why?
|
Leukemia Virus, Murine | 1 | 2001 | 1 | 0.010 |
Why?
|
Chemotaxis | 1 | 2001 | 5 | 0.010 |
Why?
|
3T3 Cells | 1 | 2001 | 10 | 0.010 |
Why?
|
Antigens, Surface | 1 | 2001 | 13 | 0.010 |
Why?
|
Genes, Reporter | 1 | 2001 | 20 | 0.010 |
Why?
|
Mice, SCID | 1 | 2001 | 27 | 0.010 |
Why?
|
Transfection | 1 | 2001 | 98 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2002 | 4503 | 0.010 |
Why?
|
Prosthesis Design | 1 | 2002 | 462 | 0.010 |
Why?
|
Kidney | 1 | 2001 | 151 | 0.010 |
Why?
|
Giant Cell Tumors | 1 | 1999 | 1 | 0.010 |
Why?
|
Tissue Distribution | 1 | 1999 | 26 | 0.010 |
Why?
|
Estrogen Receptor alpha | 1 | 1999 | 13 | 0.010 |
Why?
|
Bone Diseases | 1 | 1999 | 22 | 0.010 |
Why?
|
Giant Cells | 1 | 1997 | 2 | 0.010 |
Why?
|
Calcitriol | 1 | 1997 | 4 | 0.010 |
Why?
|
Osteoarthritis | 1 | 2002 | 303 | 0.010 |
Why?
|
Dexamethasone | 1 | 1997 | 32 | 0.010 |
Why?
|
Bone Neoplasms | 1 | 1999 | 111 | 0.010 |
Why?
|
Prospective Studies | 1 | 2002 | 1589 | 0.010 |
Why?
|
Aged | 2 | 2002 | 8397 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 1999 | 328 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 1999 | 341 | 0.010 |
Why?
|
Immune Sera | 1 | 1994 | 5 | 0.010 |
Why?
|
Antibody Specificity | 1 | 1994 | 31 | 0.010 |
Why?
|
Binding Sites, Antibody | 1 | 1992 | 3 | 0.010 |
Why?
|
Antigen-Antibody Reactions | 1 | 1992 | 5 | 0.010 |
Why?
|
Cornea | 1 | 1992 | 10 | 0.010 |
Why?
|